PTC Therapeutics Inc (PTCT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
5,230,488,000
EV to revenue ratio (TTM)
3.639
EV to ebitda
21.15
Financial Performance
Revenue (TTM)
1,008,754,000
Gross profit (TTM)
503,965,000
EBITDA
171,225,000
Profitability
Operating margin (TTM)
41.30%
Profit margin
-3.81%
Return on assets (TTM)
2.46%
Return on equity (TTM)
-7,740.00%
Per Share Metrics
Revenue per share (TTM)
12.35
EPS
-0.67
Diluted EPS (TTM)
-0.67
Book value
-1.99
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
22.73
PEG ratio
0.81
Price to sales ratio (TTM)
5.19
Price to book ratio (TTM)
1,743.27
Growth
Quarterly earnings growth (YoY)
101.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
4
Buy
7
Hold
2
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.545